Argatroban anticoagulation in obese versus nonobese patients: Implications for treating heparin-induced thrombocytopenia

被引：18
作者：
Rice, Lawrence
Hursting, Marcie J.
Baillie, G. Mark
McCollum, David A.
机构：
[1] Methodist Hosp, Weill Cornell Med Coll, Houston, TX 77030 USA
[2] Clin Sci Consulting, Austin, TX USA
[3] CTI Clin Trial & Consulting Serv, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 47卷 / 08期
关键词：
heparin-induced thrombocytopenia; obesity; argatroban; body mass index; thrombosis;
D O I：
10.1177/0091270007302951
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1028 / 1034
页数：7
相关论文
共 50 条
  • [31] Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy
    LaMonte, MP
    Brown, PM
    Hursting, MJ
    CRITICAL CARE MEDICINE, 2004, 32 (04) : 976 - 980
  • [32] Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia
    Tang, IY
    Cox, DS
    Patel, K
    Reddy, LV
    Nahlik, L
    Trevino, S
    Murray, PT
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (02) : 231 - 236
  • [33] Heparin-induced thrombocytopenia: fewer complications with argatroban
    Reactions Weekly, 2001, 859 (1) : 5 - 5
  • [34] Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: A case report
    Godier, Anne
    De Mesmay, Marine
    Becanne, Xavier
    Parisot, Marion
    Gauzit, Remy
    Samama, Charles-Marc
    Flaujac, Claire
    Horellou, Marie-Helene
    THROMBOSIS RESEARCH, 2010, 126 (02) : E141 - E143
  • [35] Recent Advances in Argatroban-Warfarin Transition in Patients With Heparin-induced Thrombocytopenia
    Taimeh, Ziad
    Weksler, Babette
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (01) : 5 - 12
  • [36] Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia
    Wallis, DE
    Quintos, R
    Wehrmacher, W
    Messmore, H
    CHEST, 1999, 116 (05) : 1333 - 1338
  • [37] Anticoagulation in patients with heparin-induced thrombocytopenia type II
    Harenberg, J
    Huhle, G
    Piazolo, L
    Wang, LCU
    Heene, DL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (02) : 189 - 196
  • [38] Heparin-Induced Thrombocytopenia Clinical Studies and the Efficacy of Argatroban in Japan
    Miyata, Shigeki
    Yamamoto, Haruko
    Kamei, Masataka
    Nakatani, Takeshi
    Kobayashi, Junjiro
    Tsuji, Tetsu
    Minematsu, Kazuo
    Tomoike, Hitonobu
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 : 37 - 47
  • [39] Argatroban in heparin-induced thrombocytopenia: rationale for use and place in therapy
    Bambrah, Ramandeep K.
    Pham, Dat C.
    Rana, Fauzia
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2013, 4 (06) : 302 - 304
  • [40] Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia
    Guzzi, Louis M.
    McCollum, David A.
    Hursting, Marcie J.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 22 (03) : 169 - 176
12345